Amiodarone (CAS 1951-25-3) – Antiarrhythmic API

Amiodarone (CAS 1951-25-3) is a high-purity class III antiarrhythmic API with a broad-spectrum mechanism of action, targeting multiple ion channels in cardiac myocytes to regulate heart rhythm. Its unique molecular structure blocks potassium, sodium, and calcium channels while non-competitively inhibiting alpha and beta adrenergic receptors, effectively suppressing atrial and ventricular arrhythmias. Produced under strict GMP-compliant processes, it ensures ultra-low impurity levels, consistent bioactivity, and compliance with international cardiovascular pharmaceutical standards.

This premium API is a core raw material for pharmaceutical manufacturers developing treatments for life-threatening cardiac arrhythmias. It is widely applied in formulating oral and injectable medications for atrial fibrillation, ventricular tachycardia, and ventricular fibrillation, serving as a first-line therapy for refractory arrhythmias in clinical settings. With proven clinical efficacy and long-lasting action, it addresses the critical demand for reliable antiarrhythmic therapies in cardiovascular care. For R&D teams and production enterprises, it provides a trusted solution to advance cardiac rhythm management drug development.